IMR OpenIR
Pharmacophore-based design, synthesis, and biological evaluation of novel 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides as cholesteryl ester transfer protein (CETP) inhibitors
其他题名Pharmacophore-based design, synthesis, and biological evaluation of novel 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides as cholesteryl ester transfer protein (CETP) inhibitors
Zhao DongMei1; Li WenYan1; Shi YuFang2; Xiong XuQiong1; Song Shuai1; Hao ChenZhou1; Cheng MaoSheng1; Shen JingKang2
2014
发表期刊CHINESE CHEMICAL LETTERS
ISSN1001-8417
卷号25期号:2页码:299-304
摘要Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that plays an important role in decreasing high-density lipoprotein cholesterol (HDL-C) levels and increasing low-density lipoprotein cholesterol (LDL-C) levels. Inhibition of CETP may be a new therapy for treating atherosclerosis. Herein, we report the development of a ligand-based pharmacophore model and pharmacophore-based virtual screening of the ZINC/big-n-greasy database, leading to the identification of compound H-10 as a potential CETP inhibitor in vitro. Based on H-10, a series of 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides were designed, synthesized, and evaluated against CETP. Compound 41 was found to have the best activity, resulting in 85.0% inhibition of CETP at 10 mu mol/L. (C) 2013 Mao-Sheng Cheng and Jing-Kang Shen. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.
其他摘要Cholesteryl ester transfer protein (CETP) is a plasma glycoprotein that plays an important role in decreasing high-density lipoprotein cholesterol (HDL-C) levels and increasing low-density lipoprotein cholesterol (LDL-C) levels. Inhibition of CETP may be a new therapy for treating atherosclerosis. Herein, we report the development of a ligand-based pharmacophore model and pharmacophore-based virtual screening of the ZINC/big-n-greasy database, leading to the identification of compound H-10 as a potential CETP inhibitor in vitro. Based on H-10, a series of 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides were designed, synthesized, and evaluated against CETP. Compound 4l was found to have the best activity, resulting in 85.0% inhibition of CETP at 10 μmol/L.
关键词CHIRAL N,N-DISUBSTITUTED TRIFLUORO-3-AMINO-2-PROPANOLS POTENT INHIBITORS DISCOVERY TRANSPORT Cholesteryl ester transfer protein CETP inhibitors Pharmacophore Virtual screening Synthesis
收录类别CSCD
语种英语
CSCD记录号CSCD:5059654
引用统计
文献类型期刊论文
条目标识符http://ir.imr.ac.cn/handle/321006/148147
专题中国科学院金属研究所
作者单位1.中国科学院金属研究所
2.Shanghai Pharmaceut Holding Co Ltd, Cent Res Institute, Shanghai 201203, Peoples R China
推荐引用方式
GB/T 7714
Zhao DongMei,Li WenYan,Shi YuFang,et al. Pharmacophore-based design, synthesis, and biological evaluation of novel 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides as cholesteryl ester transfer protein (CETP) inhibitors[J]. CHINESE CHEMICAL LETTERS,2014,25(2):299-304.
APA Zhao DongMei.,Li WenYan.,Shi YuFang.,Xiong XuQiong.,Song Shuai.,...&Shen JingKang.(2014).Pharmacophore-based design, synthesis, and biological evaluation of novel 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides as cholesteryl ester transfer protein (CETP) inhibitors.CHINESE CHEMICAL LETTERS,25(2),299-304.
MLA Zhao DongMei,et al."Pharmacophore-based design, synthesis, and biological evaluation of novel 3-((3,4-dichlorophenyl)(4-substituted benzyl)amino) propanamides as cholesteryl ester transfer protein (CETP) inhibitors".CHINESE CHEMICAL LETTERS 25.2(2014):299-304.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Zhao DongMei]的文章
[Li WenYan]的文章
[Shi YuFang]的文章
百度学术
百度学术中相似的文章
[Zhao DongMei]的文章
[Li WenYan]的文章
[Shi YuFang]的文章
必应学术
必应学术中相似的文章
[Zhao DongMei]的文章
[Li WenYan]的文章
[Shi YuFang]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。